These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 34503178)

  • 1. Enhancement of Neuroblastoma NK-Cell-Mediated Lysis through NF-kB p65 Subunit-Induced Expression of FAS and PVR, the Loss of Which Is Associated with Poor Patient Outcome.
    Brandetti E; Focaccetti C; Pezzolo A; Ognibene M; Folgiero V; Cotugno N; Benvenuto M; Palma P; Manzari V; Rossi P; Fruci D; Bei R; Cifaldi L
    Cancers (Basel); 2021 Aug; 13(17):. PubMed ID: 34503178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MYCN is an immunosuppressive oncogene dampening the expression of ligands for NK-cell-activating receptors in human high-risk neuroblastoma.
    Brandetti E; Veneziani I; Melaiu O; Pezzolo A; Castellano A; Boldrini R; Ferretti E; Fruci D; Moretta L; Pistoia V; Locatelli F; Cifaldi L
    Oncoimmunology; 2017; 6(6):e1316439. PubMed ID: 28680748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The BET-bromodomain inhibitor JQ1 renders neuroblastoma cells more resistant to NK cell-mediated recognition and killing by downregulating ligands for NKG2D and DNAM-1 receptors.
    Veneziani I; Fruci D; Compagnone M; Pistoia V; Rossi P; Cifaldi L
    Oncotarget; 2019 Mar; 10(22):2151-2160. PubMed ID: 31040907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNAM-1-chimeric receptor-engineered NK cells, combined with Nutlin-3a, more effectively fight neuroblastoma cells
    Focaccetti C; Benvenuto M; Pighi C; Vitelli A; Napolitano F; Cotugno N; Fruci D; Palma P; Rossi P; Bei R; Cifaldi L
    Front Immunol; 2022; 13():886319. PubMed ID: 35967339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroblastoma Cell Lines Are Refractory to Genotoxic Drug-Mediated Induction of Ligands for NK Cell-Activating Receptors.
    Veneziani I; Brandetti E; Ognibene M; Pezzolo A; Pistoia V; Cifaldi L
    J Immunol Res; 2018; 2018():4972410. PubMed ID: 29805983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell-Laden Hydrogel as a Clinical-Relevant 3D Model for Analyzing Neuroblastoma Growth, Immunophenotype, and Susceptibility to Therapies.
    Marrella A; Dondero A; Aiello M; Casu B; Olive D; Regis S; Bottino C; Pende D; Meazza R; Caluori G; Castriconi R; Scaglione S
    Front Immunol; 2019; 10():1876. PubMed ID: 31447858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNAM-1 Activating Receptor and Its Ligands: How Do Viruses Affect the NK Cell-Mediated Immune Surveillance during the Various Phases of Infection?
    Cifaldi L; Doria M; Cotugno N; Zicari S; Cancrini C; Palma P; Rossi P
    Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31366013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural killer cells and neuroblastoma: tumor recognition, escape mechanisms, and possible novel immunotherapeutic approaches.
    Bottino C; Dondero A; Bellora F; Moretta L; Locatelli F; Pistoia V; Moretta A; Castriconi R
    Front Immunol; 2014; 5():56. PubMed ID: 24575100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone Marrow Stromal Cell-Derived IL-8 Upregulates PVR Expression on Multiple Myeloma Cells via NF-kB Transcription Factor.
    Mekhloufi A; Kosta A; Stabile H; Molfetta R; Zingoni A; Soriani A; Cippitelli M; Paolini R; Gismondi A; Ricciardi MR; Petrucci MT; Masuelli L; Caracciolo G; Palchetti S; Santoni A; Fionda C
    Cancers (Basel); 2020 Feb; 12(2):. PubMed ID: 32069911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The requirement for DNAM-1, NKG2D, and NKp46 in the natural killer cell-mediated killing of myeloma cells.
    El-Sherbiny YM; Meade JL; Holmes TD; McGonagle D; Mackie SL; Morgan AW; Cook G; Feyler S; Richards SJ; Davies FE; Morgan GJ; Cook GP
    Cancer Res; 2007 Sep; 67(18):8444-9. PubMed ID: 17875681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytotoxic potential of IL-15-activated cytokine-induced killer cells against human neuroblastoma cells.
    Cappel C; Huenecke S; Suemmerer A; Erben S; Rettinger E; Pfirrmann V; Heinze A; Zimmermann O; Klingebiel T; Ullrich E; Bader P; Bremm M
    Pediatr Blood Cancer; 2016 Dec; 63(12):2230-2239. PubMed ID: 27433920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulation and/or release of NKG2D ligands as immune evasion strategy of human neuroblastoma.
    Raffaghello L; Prigione I; Airoldi I; Camoriano M; Levreri I; Gambini C; Pende D; Steinle A; Ferrone S; Pistoia V
    Neoplasia; 2004; 6(5):558-68. PubMed ID: 15548365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Boosting Natural Killer Cell-Mediated Targeting of Sarcoma Through DNAM-1 and NKG2D.
    Sayitoglu EC; Georgoudaki AM; Chrobok M; Ozkazanc D; Josey BJ; Arif M; Kusser K; Hartman M; Chinn TM; Potens R; Pamukcu C; Krueger R; Zhang C; Mardinoglu A; Alici E; Temple HT; Sutlu T; Duru AD
    Front Immunol; 2020; 11():40. PubMed ID: 32082316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apoptosis induced in T cells by human neuroblastoma cells: role of Fas ligand.
    Shurin GV; Gerein V; Lotze MT; Barksdale EM
    Nat Immun; 1998; 16(5-6):263-74. PubMed ID: 11061594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of PVR (CD155) and Nectin-2 (CD112) as cell surface ligands for the human DNAM-1 (CD226) activating molecule.
    Bottino C; Castriconi R; Pende D; Rivera P; Nanni M; Carnemolla B; Cantoni C; Grassi J; Marcenaro S; Reymond N; Vitale M; Moretta L; Lopez M; Moretta A
    J Exp Med; 2003 Aug; 198(4):557-67. PubMed ID: 12913096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural killer cell-mediated killing of freshly isolated neuroblastoma cells: critical role of DNAX accessory molecule-1-poliovirus receptor interaction.
    Castriconi R; Dondero A; Corrias MV; Lanino E; Pende D; Moretta L; Bottino C; Moretta A
    Cancer Res; 2004 Dec; 64(24):9180-4. PubMed ID: 15604290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of immune evasion of human neuroblastoma.
    Raffaghello L; Prigione I; Airoldi I; Camoriano M; Morandi F; Bocca P; Gambini C; Ferrone S; Pistoia V
    Cancer Lett; 2005 Oct; 228(1-2):155-61. PubMed ID: 15923080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of Fas-ligand by neuroblastoma: a novel mechanism of tumor-cell killing.
    Takamizawa S; Okamoto S; Wen J; Bishop W; Kimura K; Sandler A
    J Pediatr Surg; 2000 Feb; 35(2):375-9. PubMed ID: 10693700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential expression of ligands for NKG2D and DNAM-1 receptors by epithelial ovarian cancer-derived exosomes and its influence on NK cell cytotoxicity.
    Labani-Motlagh A; Israelsson P; Ottander U; Lundin E; Nagaev I; Nagaeva O; Dehlin E; Baranov V; Mincheva-Nilsson L
    Tumour Biol; 2016 Apr; 37(4):5455-66. PubMed ID: 26563374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differentiation-related expression of adhesion molecules and receptors on human neuroblastoma tissues, cell lines and variants.
    Gross N; Favre S; Beck D; Meyer M
    Int J Cancer; 1992 Aug; 52(1):85-91. PubMed ID: 1354203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.